Why new Omicron subvariant JN.1 is a global concern | India News – Times of India

 Why new Omicron subvariant JN.1 is a global concern | India News - Times of India

New Delhi: A new subtype, JN.1, of the coronavirus that causes Covid-19 has been identified in a woman in Kerala, raising concerns and calling for continued vigilance in the fight against the viral disease. The need is emphasized.
The Center on December 16 confirmed the presence of the JN.1 subtype of CoVID-19 in a patient from Kerala, the first such case in India.Parolewhich has recently been detected in the US and China. A sample from a Covid-positive patient, according to the government Thiruvananthapuram Positive came for JN.1 on December 8 as part of ongoing routine surveillance.
What is JN.1?
This virus is a new version of Omicron subvariant BA.2.86, (also known as Perola) of SARS-CoV-2. This carries an additional mutation on its spike protein. The variant has the potential to spread rapidly and escape immunity, highlighting the need for constant surveillance and vigilance in response to the changing situation in India.

What are the symptoms?
Symptoms of CoVID-19 remain the same in all strains. As suggested by the US health agency CDC, JN.1 may or may not cause different symptoms compared to other coronavirus variants. Symptoms reported by JN.1 include fever, runny nose, sore throat, headache, and mild gastrointestinal symptoms.
Should we worry about it?
The CDC has warned that it lacks information on whether the strain shows symptoms distinct from earlier coronavirus variants. The agency warns that JN.1 shows a high ability to evade the immune system, raising concerns about increased transmissibility.

WHO urges ‘intense surveillance’
In the wake of the surge, the World Health Organization (WHO) urged member states to continue to share robust surveillance and coordination.
The global body also shared a video of its Covid-19 technological breakthrough. Maria von Kirkhofwho explained the reason for the recent increase and what preventive measures can be taken.
“Dr. @mvankerkhove talks about the current increase in respiratory diseases #COVID19 and the JN.1 subtype. WHO is monitoring the situation. WHO to keep your family and friends safe this holiday season. Follow the public health advice of,” WHO posted on X (formerly Twitter).

Maria von Kerkhoff also took to the social media platform and said that several pathogens have led to an increase in respiratory diseases worldwide.
“Respiratory diseases are on the rise worldwide due to multiple pathogens including #COVID19, #flu, rhinovirus, mycoplasma pneumoniae and others. SARS-CoV-2 continues to evolve. JN.1 (sub.BA.2.86) first is the VOI and circulation continues to increase,” he said.

Global concerns
China has identified seven cases of Covid caused by subvariant JN.1, which has an additional spike protein mutation. Discovered in the US in September 2023, the JN.1 has since appeared in 11 other countries. The CDC recommends that it is too early to predict its wider spread based on current information, emphasizing the need for ongoing surveillance.
Meanwhile, India on Sunday registered 335 new Covid-19 infections while the number of active cases rose to 1,701. Union Ministry of Health. Health officials have stressed the importance of vigilance, advocating precautions such as hand hygiene, up-to-date vaccinations, and seeking immediate medical attention for any worrisome symptoms.
A mock exercise is underway in health facilities across states to assess public health and hospital preparedness. The exercise, overseen by the District Collector, began on December 13 and is scheduled to be completed by December 18, 2023.
While most of the cases in Kerala are reported to be clinically mild, health officials stress the importance of continued vigilance and preparedness to effectively manage the emerging situation of the Covid-19 variant.
The India SARS-CoV-2 Genomics Consortium (INSACOG), a network of genomic laboratories, is actively monitoring the genomic aspects of CoVID-19 in India.
Health officials highlight that most patients experience mild upper respiratory symptoms, which usually improve within four to five days.

Hospitals, health centers to increase testing: Cuttack health minister after reports of new COVID-19 strain cases in Kerala

India,India News,India news today.,Today’s news,Google News,Latest news,World Health Organization,Union Ministry of Health,Thiruvananthapuram,Parole,Maria van Kerkhoff,covid

Be the first to comment

Leave a Reply

Your email address will not be published.